Accuray (ARAY) stock surged 42% premarket following a strategic CyberKnife imaging partnership with Samsung NeuroLogica.
The agreements bring together mobile CT capabilities and precision treatment delivery expertise to improve anatomical visualisation during radiotherapy.
Accuray Inc.’s (NASDAQ:ARAY) recent agreement with RaySearch Laboratories around an extended alliance, is a major step toward online adaptive radiation therapy. The integration of Accuray’s imaging technology and photon-based radiation therapy platforms with RaySearch’s proprietary planning and workflow solutions, will fast-track innovation across the space. For Accuray, the arrangement will also accelerate its adoption to […]
On August 19, Accuray Incorporated (NASDAQ:ARAY) held its fiscal fourth-quarter and full-year 2026 earnings call, laying out a business caught between a genuine financial rescue and a China market that is still bleeding revenue. Total net revenue fell 21% in the quarter to $100.9 million, and the company won’t even offer a forecast for the […]
Motley Fool Press Release.
This is the newest page. Registered accounts read further back.